View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AH89 | Publication ID: Spring 2018 |
Title: Format and Content of Reports Intended to Demonstrate Substantial Equivalence | |
Abstract:
This proposed rule would establish the format and content of reports intended to demonstrate substantial equivalence (SE) in tobacco products and would provide information as to how the Agency will review and act on these submissions. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: Undetermined |
EO 13771 Designation: Other | |
CFR Citation: 21 CFR 1107 | |
Legal Authority: 21 U.S.C. 371 21 U.S.C. 374 21 U.S.C. 387 42 U.S.C. 4332 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: Yes | |
RIN Data Printed in the FR: No | |
Agency Contact: Annette Marthaler Senior Regulatory Counsel Department of Health and Human Services Food and Drug Administration Office of Combination Products, 10903 New Hampshire Avenue, WO32, Room 5129, Silver Spring, MD 20993 Phone:240 753-3043 Email: annette.marthaler@fda.hhs.gov |